LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

Search

Abbott Laboratories

Closed

Sector Healthcare

105.58 -0.84

Overview

Share price change

24h

Current

Min

105.28

Max

105.85

Key metrics

By Trading Economics

Income

-369M

1.2B

Sales

-281M

10B

P/E

Sector Avg

37.327

23.904

EPS

0.98

Dividend yield

1.871

Profit margin

12.299

Employees

114,000

EBITDA

-28M

2.4B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+20.84 upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.87%

7.76%

Next Earnings

18 lip 2024

Next Dividend date

15 sie 2024

Next Ex Dividend date

15 lip 2024

Market Stats

By TradingEconomics

Market Cap

174M

179B

Previous open

106.42

Previous close

105.58

News Sentiment

By Acuity

43%

57%

85 / 369 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Abbott Laboratories Chart

Related News

24 sty 2024, 13:04 UTC

Earnings

Abbott Labs Posts Higher 4Q Sales, Despite Soft Demand For Covid Tests

17 kwi 2024, 13:54 UTC

Earnings

Abbott Labs Stock Is Slipping After Earnings Beat. Here's Why. -- Barrons.com

17 kwi 2024, 12:41 UTC

Top News
Earnings

Abbott Labs Stock Is Slipping. Disappointing Guidance Trumps a Strong Quarter. -- Barrons.com

17 kwi 2024, 11:52 UTC

Earnings

Abbott Labs Jumps, Retreats On Q1 Beat, Shy Guidance -- IBD

17 kwi 2024, 11:45 UTC

Earnings

Abbott Labs First-Quarter Results Top Estimates Amid Strong Medical Device Sales -- MarketWatch

17 kwi 2024, 11:32 UTC

Earnings

Abbott Labs Narrows 2024 Organic Sales Growth Ex-Covid-19 View to 8.5%-10% >ABT

17 kwi 2024, 11:30 UTC

Earnings

Abbott Labs 1Q Organic Sales for Underlying Base Business Rose 10.8% >ABT

17 kwi 2024, 11:30 UTC

Earnings

Abbott Raises Midpoint of Full-Year Guidance Ranges >ABT

17 kwi 2024, 11:30 UTC

Earnings

Abbott Labs Sees FY Adj EPS $4.55-Adj EPS $4.70 >ABT

17 kwi 2024, 11:30 UTC

Earnings

Abbott Labs 1Q Adj EPS 98c >ABT

17 kwi 2024, 11:30 UTC

Earnings

Abbott Labs 1Q EPS 70c >ABT

17 kwi 2024, 11:30 UTC

Earnings

Abbott Labs Sees FY EPS $3.25-EPS $3.40 >ABT

17 kwi 2024, 11:30 UTC

Earnings

Abbott Labs 1Q Net $1.23B >ABT

17 kwi 2024, 11:30 UTC

Earnings

Abbott Labs 1Q Organic Sales Growth Up 4.7% >ABT

17 kwi 2024, 11:30 UTC

Earnings

Abbott Labs 1Q Sales $9.96B >ABT

17 kwi 2024, 10:05 UTC

Hot Stocks

Stocks to Watch Wednesday: United Airlines, Alcoa, Adidas, ASML -- WSJ

17 kwi 2024, 09:03 UTC

Hot Stocks

Stocks to Watch Wednesday: United Airlines, ASML, Adidas -- WSJ

24 sty 2024, 15:13 UTC

Earnings

Abbott Labs Shares Are Down Despite Solid Profit Increase -- WSJ

24 sty 2024, 13:55 UTC

Top News
Earnings

Abbott Labs Skids On Light Earnings Guidance Despite Quarterly Sales Beat -- IBD

24 sty 2024, 13:01 UTC

Earnings

Abbott Laboratories Stock Is Down. Earnings, Sales Aren't the Problem. -- Barrons.com

24 sty 2024, 12:34 UTC

Earnings

Abbott Labs Sees FY24Organic Sales Growth, Excluding COVID-19 Testing-Related Sales, to Be in the Range of 8.0% to 10.0% >ABT

24 sty 2024, 12:33 UTC

Earnings

Abbott Labs Sees FY24 Adj EPS $4.50-Adj EPS $4.70 >ABT

24 sty 2024, 12:33 UTC

Earnings

Abbott Labs Sees FY24 EPS $3.20-EPS $3.40 >ABT

24 sty 2024, 12:30 UTC

Earnings

Abbott Labs 4Q Organic Sales Growth Up 2.1% >ABT

24 sty 2024, 12:30 UTC

Earnings

Abbott Labs 4Q EPS 91c >ABT

24 sty 2024, 12:30 UTC

Earnings

Abbott Labs 4Q Sales $10.24B >ABT

24 sty 2024, 12:30 UTC

Earnings

Abbott Labs 4Q Net $1.59B >ABT

24 sty 2024, 12:30 UTC

Earnings

Abbott Labs Sees FY Adj EPS $4.50-Adj EPS $4.70 >ABT

24 sty 2024, 12:30 UTC

Earnings

Abbott Labs 4Q Adj EPS $1.19 >ABT

24 sty 2024, 12:30 UTC

Earnings

Abbott Labs Sees FY EPS $3.20-EPS $3.40 >ABT

Peer Comparison

Price change

Abbott Laboratories Forecast

Price Target

By TipRanks

20.84% upside

12 Months Forecast

Average 127.75 USD  20.84%

High 140 USD

Low 115 USD

Based on 12 Wall Street analysts offering 12 month price targets forAbbott Laboratories - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

11

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

103.3701 / 107.58Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Weak Bearish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

85 / 369 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Abbott Laboratories

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.